{"id":1054,"date":"2024-12-05T18:01:32","date_gmt":"2024-12-05T10:01:32","guid":{"rendered":"https:\/\/cn.dailyeconomic.com\/en\/?p=1054"},"modified":"2024-12-05T18:01:32","modified_gmt":"2024-12-05T10:01:32","slug":"nz-patient-celebrates-birthday-with-gift-of-new-life-in-shanghai","status":"publish","type":"post","link":"https:\/\/cn.dailyeconomic.com\/en\/2024\/12\/05\/nz-patient-celebrates-birthday-with-gift-of-new-life-in-shanghai\/","title":{"rendered":"NZ patient celebrates birthday with gift of new life in Shanghai"},"content":{"rendered":"<p>For 57-year-old Dale from New Zealand, his best birthday gift this year was to be pronounced free of cancer by doctors from the Shanghai SinoUnited Hospital, where Dale received advanced CAR-T cell immunotherapy three months ago to treat his lymphoma. He had returned for a check to determine the results.<\/p>\n<p>China has become a leading medical center for CAR-T cell immunotherapy. So far, there are six CAR-T products approved in the nation and four were either developed or manufactured in Shanghai. This has attracted many overseas patients to the city for treatment, which offers high quality at a competitive price.<\/p>\n<p>CAR-T, or chimeric antigen receptor T cell therapy, is specifically developed for each patient by reprogramming the patient&#8217;s own immune cells to target the cancer. It is a complicated treatment requiring close monitoring and multidisciplinary professionals during patient selection, bridging treatment, side effect control, and symptom management.<\/p>\n<p>&#8220;Since China has been taking the position on leading CAR-T therapy in the world, we have gained much experience in patient treatment and management to reduce complications and ensure good treatment outcome,&#8221; said Dr Lily Zhou from the Shanghai SinoUnited Hospital, which discharged Dale on Monday after his checkup and celebrated his success in beating the disease.<\/p>\n<p><img decoding=\"async\" class=\"aligncenter\" src=\"http:\/\/objectem.oss-cn-shenzhen.aliyuncs.com\/yhdoc\/202412\/05\/202412051741151072816888.jpeg\" \/><\/p>\n<p style=\"text-align: center\">Dale from New Zealand smiles while undergoing CAR-T infusion at the Shanghai SinoUnited Hospital in September<\/p>\n<p><img decoding=\"async\" class=\"aligncenter\" src=\"http:\/\/objectem.oss-cn-shenzhen.aliyuncs.com\/yhdoc\/202412\/05\/202412051741151990750289.jpeg\" \/><\/p>\n<p style=\"text-align: center\">Dr Lily Zhou checks Dale before he is discharged on Monday after a checkup confirmed his cancer-free status<\/p>\n<p style=\"text-align: left\">&#8220;So far there are six CAR-T options available in China, covering all major targets for various blood diseases. China&#8217;s research and practice of CAR-T are in a leading position, making it a hot destination for international patients, while the price here is only about one-fifth that in the US,&#8221; said Zhou, chief of hematology at SinoUnited Health.<\/p>\n<p>&#8220;All our foreign patients are reporting positive effects, which is very encouraging. The Yikaida used on Dale is the first approved CAR-T product in China. It is produced in Shanghai.<\/p>\n<p>&#8220;He has achieved complete remission, which means cancer free, just one month later and this checkup three months later confirmed he was cancer free on a PET-CT scan. It is a very good result.&#8221;<\/p>\n<p>Dale came to Shanghai SinoUnited Hospital after three unsuccessful rounds of chemotherapy in New Zealand, and chose the hospital after interviewing a couple of others.<\/p>\n<p>&#8220;The whole treatment is smooth here,&#8221; he said. &#8220;I celebrated my birthday with doctors and nurses here on Friday and I am very grateful to them, who are my friends now. It&#8217;s a good experience for me. Nobody wants to get cancer but the treatment here is very successful and gives me new lease of life.&#8221;<\/p>\n<p>Dr Kathy Shi, chief executive officer of SinoUnited Health, said the hospital boasted an international medical team and about 40 percent of its patients came from overseas.<\/p>\n<p>&#8220;So we are very active in attracting international patients and participating in the local government&#8217;s campaign of encouraging international medical tourism, which requires high-quality medical capability, good language ability and patient-centered service, including picking up patients at the airport, food, cultural background, a multidisciplinary medical team, and competitive price,&#8221; Shi said.<\/p>\n<p>&#8220;All our medical perspectives are designed based on patient demand. Taking patients for CAR-T as example, doctors from different departments will take part in the treatment to offer support whenever there is a demand. We also give mental support to give patients the best experience,&#8221; she said.<\/p>\n<p><img decoding=\"async\" class=\"aligncenter\" src=\"http:\/\/objectem.oss-cn-shenzhen.aliyuncs.com\/yhdoc\/202412\/05\/20241205174115716376527.jpeg\" \/><\/p>\n<p style=\"text-align: center\">Dr Kathy Shi, chief executive officer of SinoUnited Health, talks about international medical tourism in Shanghai<\/p>\n<p><img decoding=\"async\" class=\"aligncenter\" src=\"http:\/\/objectem.oss-cn-shenzhen.aliyuncs.com\/yhdoc\/202412\/05\/202412051741151419906505.jpeg\" \/><\/p>\n<p style=\"text-align: center\">Dale and Dr Lily Zhou celebrate the success of his CAR-T treatment in Shanghai<\/p>\n<p>Reprinted from Shanghai Daily.<\/p>\n","protected":false},"excerpt":{"rendered":"<div class=\"mh-excerpt\"><p>For 57-year-old Dale from New Zealand, his best birthday gift this year was to be pronounced free of cancer by doctors from the Shanghai SinoUnited Hospital, where Dale received advanced CAR-T cell immunotherapy three months <a class=\"mh-excerpt-more\" href=\"https:\/\/cn.dailyeconomic.com\/en\/2024\/12\/05\/nz-patient-celebrates-birthday-with-gift-of-new-life-in-shanghai\/\" title=\"NZ patient celebrates birthday with gift of new life in Shanghai\">[&#8230;]<\/a><\/p>\n<\/div>","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1054","post","type-post","status-publish","format-standard","category-business"],"_links":{"self":[{"href":"https:\/\/cn.dailyeconomic.com\/en\/wp-json\/wp\/v2\/posts\/1054","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cn.dailyeconomic.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cn.dailyeconomic.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cn.dailyeconomic.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cn.dailyeconomic.com\/en\/wp-json\/wp\/v2\/comments?post=1054"}],"version-history":[{"count":1,"href":"https:\/\/cn.dailyeconomic.com\/en\/wp-json\/wp\/v2\/posts\/1054\/revisions"}],"predecessor-version":[{"id":1055,"href":"https:\/\/cn.dailyeconomic.com\/en\/wp-json\/wp\/v2\/posts\/1054\/revisions\/1055"}],"wp:attachment":[{"href":"https:\/\/cn.dailyeconomic.com\/en\/wp-json\/wp\/v2\/media?parent=1054"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cn.dailyeconomic.com\/en\/wp-json\/wp\/v2\/categories?post=1054"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cn.dailyeconomic.com\/en\/wp-json\/wp\/v2\/tags?post=1054"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}